These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20932662)

  • 1. Early side effects of three-dimensional conformal external beam accelerated partial breast irradiation to a total dose of 40 Gy in one week (a phase II trial).
    Bourgier C; Pichenot C; Verstraet R; El Nemr M; Heymann S; Biron B; Delaloge S; Mathieu MC; Garbay JR; Bourhis J; Taghian AG; Marsiglia H
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1228-35. PubMed ID: 20932662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial dosimetric experience using simple three-dimensional conformal external-beam accelerated partial-breast irradiation.
    Taghian AG; Kozak KR; Doppke KP; Katz A; Smith BL; Gadd M; Specht M; Hughes K; Braaten K; Kachnic LA; Recht A; Powell SN
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1092-9. PubMed ID: 16406392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy.
    Vicini FA; Chen P; Wallace M; Mitchell C; Hasan Y; Grills I; Kestin L; Schell S; Goldstein NS; Kunzman J; Gilbert S; Martinez A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1124-30. PubMed ID: 17967306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319.
    Vicini F; Winter K; Straube W; Wong J; Pass H; Rabinovitch R; Chafe S; Arthur D; Petersen I; McCormick B
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1531-7. PubMed ID: 16198508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated partial breast irradiation using proton beams: Initial dosimetric experience.
    Taghian AG; Kozak KR; Katz A; Adams J; Lu HM; Powell SN; DeLaney TF
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1404-10. PubMed ID: 16730137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation.
    Chen PY; Wallace M; Mitchell C; Grills I; Kestin L; Fowler A; Martinez A; Vicini F
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):991-7. PubMed ID: 19515514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Accelerated partial breast irradiation: bifractionated 40Gy in one week. A French pilot phase II study].
    Bourgier C; Pichenot C; Verstraet R; Heymann S; Biron B; Balleyguier C; Delaloge S; Mathieu MC; Uzan C; Garbay JR; Bourhis J; Taghian A; Marsiglia H
    Cancer Radiother; 2010 Dec; 14(8):718-26. PubMed ID: 20674444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prone accelerated partial breast irradiation after breast-conserving surgery: compliance to the dosimetry requirements of RTOG-0413.
    Wen B; Hsu H; Formenti-Ujlaki GF; Lymberis S; Magnolfi C; Zhao X; Chang J; DeWyngaert JK; Jozsef G; Formenti SC
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):910-6. PubMed ID: 22543213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation.
    Rodríguez N; Sanz X; Dengra J; Foro P; Membrive I; Reig A; Quera J; Fernández-Velilla E; Pera Ó; Lio J; Lozano J; Algara M
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1051-7. PubMed ID: 24161420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher toxicity with 42 Gy in 10 fractions as a total dose for 3D-conformal accelerated partial breast irradiation: results from a dose escalation phase II trial.
    Bourgier C; Acevedo-Henao C; Dunant A; Rossier C; Levy A; El Nemr M; Dumas I; Delaloge S; Mathieu MC; Garbay JR; Taghian A; Marsiglia H
    Radiat Oncol; 2012 Aug; 7():141. PubMed ID: 22913640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying patients who are unsuitable for accelerated partial breast irradiation using three-dimensional external beam conformal techniques.
    Shikama N; Nakamura N; Kunishima N; Hatanaka S; Sekiguchi K
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e313-8. PubMed ID: 22417799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric comparison of four different external beam partial breast irradiation techniques: three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, and proton beam therapy.
    Moon SH; Shin KH; Kim TH; Yoon M; Park S; Lee DH; Kim JW; Kim DW; Park SY; Cho KH
    Radiother Oncol; 2009 Jan; 90(1):66-73. PubMed ID: 18992950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of 3D-conformal accelerated partial breast irradiation: lessons learned from patients and physicians' evaluation.
    Azoury F; Heymann S; Acevedo C; Spielmann M; Vielh P; Garbay JR; Taghian AG; Marsiglia H; Bourgier C
    Radiother Oncol; 2012 May; 103(2):193-8. PubMed ID: 22521749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
    Brabbins D; Martinez A; Yan D; Lockman D; Wallace M; Gustafson G; Chen P; Vicini F; Wong J
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):400-8. PubMed ID: 15667959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric comparison of two different three-dimensional conformal external beam accelerated partial breast irradiation techniques.
    Kozak KR; Doppke KP; Katz A; Taghian AG
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):340-6. PubMed ID: 16690427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.
    Michalski JM; Winter K; Purdy JA; Perez CA; Ryu JK; Parliament MB; Valicenti RK; Roach M; Sandler HM; Markoe AM; Cox JD
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):735-42. PubMed ID: 14967428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
    Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multisegmented tangential breast fields: a rational way to treat breast cancer.
    Gulybán A; Kovács P; Sebestyén Z; Farkas R; Csere T; Karácsonyi G; Dérczy K; Hideghéty K; Esik O
    Strahlenther Onkol; 2008 May; 184(5):262-9. PubMed ID: 18427757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of dose-volume parameters and interfraction interval on cosmetic outcome and toxicity after 3-dimensional conformal accelerated partial breast irradiation.
    Leonard KL; Hepel JT; Hiatt JR; Dipetrillo TA; Price LL; Wazer DE
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):623-9. PubMed ID: 22867895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late toxicity and patient self-assessment of breast appearance/satisfaction on RTOG 0319: a phase 2 trial of 3-dimensional conformal radiation therapy-accelerated partial breast irradiation following lumpectomy for stages I and II breast cancer.
    Chafe S; Moughan J; McCormick B; Wong J; Pass H; Rabinovitch R; Arthur DW; Petersen I; White J; Vicini FA
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):854-9. PubMed ID: 23726000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.